Sean E. Browne - 15 Aug 2025 Form 4 Insider Report for Xtant Medical Holdings, Inc. (XTNT)

Role
President and CEO, Director
Signature
/s/ Amy Culbert, attorney-in-fact
Issuer symbol
XTNT
Transactions as of
15 Aug 2025
Net transactions value
-$6,681
Form type
4
Filing time
19 Aug 2025, 16:45:36 UTC
Previous filing
16 Oct 2024
Next filing
18 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Browne Sean E President and CEO, Director C/O XTANT MEDICAL HOLDINGS, INC., 664 CRUISER LANE, BELGRADE /s/ Amy Culbert, attorney-in-fact 19 Aug 2025 0001790461

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XTNT Common Stock Tax liability $6,681 -10,605 -0.48% $0.6300 2,180,337 15 Aug 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were withheld by the Issuer to pay tax withholding obligations upon vesting and settlement of restricted stock unit awards.
F2 Includes an aggregate of 818,740 shares issuable upon vesting and settlement of restricted stock unit awards or deferred stock unit awards granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan, in each case conditioned upon the Reporting Person remaining an employee of Xtant through the respective vesting dates.